Aged
C. R. Jack, Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., Roberts, R. O., Rocca, W. A., Boeve, B. F., and Petersen, R. C.,
“An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.”,
Ann Neurol, vol. 71, no. 6, pp. 765-75, 2012.
Aged, 80 and over
C. R. Jack, Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., Roberts, R. O., Rocca, W. A., Boeve, B. F., and Petersen, R. C.,
“An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.”,
Ann Neurol, vol. 71, no. 6, pp. 765-75, 2012.
Alzheimer Disease
C. R. Jack, Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., Roberts, R. O., Rocca, W. A., Boeve, B. F., and Petersen, R. C.,
“An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.”,
Ann Neurol, vol. 71, no. 6, pp. 765-75, 2012.
Aniline Compounds
C. R. Jack, Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., Roberts, R. O., Rocca, W. A., Boeve, B. F., and Petersen, R. C.,
“An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.”,
Ann Neurol, vol. 71, no. 6, pp. 765-75, 2012.
Biomarkers
C. R. Jack, Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., Roberts, R. O., Rocca, W. A., Boeve, B. F., and Petersen, R. C.,
“An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.”,
Ann Neurol, vol. 71, no. 6, pp. 765-75, 2012.
Brain
C. R. Jack, Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., Roberts, R. O., Rocca, W. A., Boeve, B. F., and Petersen, R. C.,
“An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.”,
Ann Neurol, vol. 71, no. 6, pp. 765-75, 2012.
Cognition Disorders
C. R. Jack, Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., Roberts, R. O., Rocca, W. A., Boeve, B. F., and Petersen, R. C.,
“An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.”,
Ann Neurol, vol. 71, no. 6, pp. 765-75, 2012.
Disease Progression
C. R. Jack, Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., Roberts, R. O., Rocca, W. A., Boeve, B. F., and Petersen, R. C.,
“An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.”,
Ann Neurol, vol. 71, no. 6, pp. 765-75, 2012.
Female
C. R. Jack, Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., Roberts, R. O., Rocca, W. A., Boeve, B. F., and Petersen, R. C.,
“An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.”,
Ann Neurol, vol. 71, no. 6, pp. 765-75, 2012.
Fluorodeoxyglucose F18
C. R. Jack, Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., Roberts, R. O., Rocca, W. A., Boeve, B. F., and Petersen, R. C.,
“An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.”,
Ann Neurol, vol. 71, no. 6, pp. 765-75, 2012.
Humans
C. R. Jack, Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., Roberts, R. O., Rocca, W. A., Boeve, B. F., and Petersen, R. C.,
“An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.”,
Ann Neurol, vol. 71, no. 6, pp. 765-75, 2012.
Longitudinal Studies
C. R. Jack, Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., Roberts, R. O., Rocca, W. A., Boeve, B. F., and Petersen, R. C.,
“An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.”,
Ann Neurol, vol. 71, no. 6, pp. 765-75, 2012.
Male
C. R. Jack, Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., Roberts, R. O., Rocca, W. A., Boeve, B. F., and Petersen, R. C.,
“An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.”,
Ann Neurol, vol. 71, no. 6, pp. 765-75, 2012.
Mental Status Schedule
C. R. Jack, Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., Roberts, R. O., Rocca, W. A., Boeve, B. F., and Petersen, R. C.,
“An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.”,
Ann Neurol, vol. 71, no. 6, pp. 765-75, 2012.
National Institute on Aging (U.S.)
C. R. Jack, Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., Roberts, R. O., Rocca, W. A., Boeve, B. F., and Petersen, R. C.,
“An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.”,
Ann Neurol, vol. 71, no. 6, pp. 765-75, 2012.
Neuropsychological Tests
C. R. Jack, Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., Roberts, R. O., Rocca, W. A., Boeve, B. F., and Petersen, R. C.,
“An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.”,
Ann Neurol, vol. 71, no. 6, pp. 765-75, 2012.
Positron-Emission Tomography
C. R. Jack, Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., Roberts, R. O., Rocca, W. A., Boeve, B. F., and Petersen, R. C.,
“An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.”,
Ann Neurol, vol. 71, no. 6, pp. 765-75, 2012.
Thiazoles
C. R. Jack, Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., Roberts, R. O., Rocca, W. A., Boeve, B. F., and Petersen, R. C.,
“An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.”,
Ann Neurol, vol. 71, no. 6, pp. 765-75, 2012.
United States
C. R. Jack, Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., Roberts, R. O., Rocca, W. A., Boeve, B. F., and Petersen, R. C.,
“An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.”,
Ann Neurol, vol. 71, no. 6, pp. 765-75, 2012.